Chen Samuel

Chen Samuel is an experienced clinical research professional currently serving as the BPM Evidence Delivery Power Hub Director within the Global Evidence team at AstraZeneca. They oversee evidence delivery activities in the Respiratory Inhaled portfolio, ensuring alignment with business objectives through effective senior-level collaboration. Chen's extensive background includes roles such as Evidence Delivery Lead, Clinical Project Manager, and Clinical Development Leader across various therapeutic areas, highlighting their strong competencies in project management, leadership, and cross-functional teamwork. They hold a Master of Science in Chemistry from the University of Gothenburg.